T20H4.4 | Evidence | Paper_evidence | WBPaper00005596
|
| SMap | S_parent | Sequence | SUPERLINK_RW3B
|
| Chromosome | III |
|
Identity (5)
|
|
Gene_info
| Gene_class | adr
|
| |
Allele
|
gv42
| Paper_evidence | WBPaper00005596
|
| | | |
Inferred_automatically
| From strain object: BB3 |
| | | | | From strain object: BB4 |
| | | ok735
| Inferred_automatically | From strain object: RB886 |
| | | tm670
|
| | | CE3-159
|
| |
Strain
| BB3
|
| | | BB4
|
| | | RB886
|
| |
GO_term (5)
|
| | Contained_in_operon | CEOP3424
|
| |
Structured_description
|
Provisional_description
| adr-2 encodes an adenosine deaminase that acts on RNA (ADAR); ADARs are RNA-editing enzymes that deaminate adenosines to create inosines in double-stranded RNA (dsRNA); adr-2 is expressed ubiquitously in early embryos, as well as in the germline of early adults; ADR-2 is required for ADAR activity in vivo, and for normal chemotaxis. |
Paper_evidence (8)
|
| | | | | Person_evidence | WBPerson567
|
| | | | | Curator_confirmed | WBPerson567
|
| | | | | Date_last_updated | 17 Jun 2004 00:00:00 |
| | | | adr-2(gv42) mutants show no ADAR activity either in vitro (from extracts of mixed-stage whole worms) on an artificial substrate, or in vivo on 256 sites of ADAR action on natural mRNA substrates. |
| | | | Despite the complete loss of ADAR activity in adr-2(gv42) mutants, they display normal vulval development, in contrast to adr-1(gv6) mutants which show a mix of partial ADAR loss and partial ADAR hyperactivity. |
| | | | The putative catalytic site of ADR-1 is divergent from the consensus sequence found in most ADARs (including ADR-2), which suggests that ADR-1 might form a catalytically inactive heteromeric subunit with ADR-2. |
| | | Concise_description | adr-2 encodes an adenosine deaminase that acts on RNA (ADAR); ADARs are RNA-editing enzymes that deaminate adenosines to create inosines in double-stranded RNA (dsRNA); adr-2 is expressed ubiquitously in early embryos, as well as in the germline of early adults; ADR-2 is required for ADAR activity in vivo, and for normal chemotaxis. |
|
Molecular_info (5)
|
|
Experimental_info
|
RNAi_result
| Cenix:305-b3
|
| | | JA:T20H4.4
|
| | | TH:305B3
|
| |
WB_RNAi_result
| TH:305B3
|
| | | JA:T20H4.4
|
| | | MV_SV:mv_AAC25097
|
| | | Cenix:305-b3
|
| |
Y2H_bait
| Y2H002211
|
| | | Y2H002213
|
| | Y2H_target | Y2H009400
|
|
Reference (6)
|
| Remark | Map position created from combination of previous interpolated map position (based on known location of sequence) and allele information. Therefore this is not a genetic map position based on recombination frequencies or genetic experiments. This was done on advice of the CGC. | CGC_data_submission |
| Method | Gene
|